bf/NASDAQ:BCDA_icon.jpeg

NASDAQ:BCDAW

BioCardia, Inc.

  • Stock

2.85

−9.24%

1.11

USD last updated 13/08 01:59:42

Last Close

1.74

12/08 20:48

Market Cap

5.52M

Beta: -

Volume Today

115.31K

Avg: -

PE Ratio

−0.73

PFCF: −0.82

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also develo...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.15-0.1-0.052022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    Revenue (Estimate*)

    100K200K300K400K2022-12-312022-12-302023-03-312023-03-302023-06-302023-06-292023-09-302023-09-29

    *Estimate based on analyst consensus